Follow-The-Filings

Security · featured owners

CBIO Crescent Biopharma Inc.

Health Care COM Equity as of 2026 Q2 among managers we track

  • 1 Owner
  • Max 2.2%
  • $24M
  • 1 add

Who owns this now

Largest portfolio weights among featured holders · max 2.2% (James Silverman - Opaleye Management) · not free-float ownership

  1. James Silverman add 2.2%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
James Silverman - Opaleye Management 2026 Q2 2.2% Add +0.5% 1,319,351 $24M history

1 current · options excluded

SEC filings

Recent issuer filings from EDGAR · 21 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
424B3 Filing Doc
424B5 Filing Doc
8-K 8.01,9.01 Filing Doc
424B5 Filing Doc
8-K 2.02 Filing Doc
10-Q/A Filing Doc
424B3 Filing Doc
8-K 5.07 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
424B3 Filing Doc
DEFA14A Filing Doc
DEFA14A Filing Doc
424B3 Filing Doc
10-K Filing Doc
8-K 2.02,9.01 Filing Doc
424B3 Filing Doc
424B3 Filing Doc
S-1 Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 4 rows shown

Filed Form Detail Links
4 Period Jul 16, 2026 Filing Doc
4 Period Jun 22, 2026 · 7 forms Filing Doc
4 Period Jun 2, 2026 · 5 forms Filing Doc
4 Period Dec 15, 2025 · 6 forms Filing Doc

Updated about 16 hours ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue — — $10.84M
Net income -$36.9M -$37.88M -$153.94M
Net margin * — — -1419.6%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $43.79M $11.09M $236.66M
Total non-current assets * $1.53M $0M $3.64M
Total assets $45.32M $11.09M $240.29M
Total current liabilities $6.84M $5.78M $36.07M
Total non-current liabilities * $0.067M $0M $1.21M
Total equity $38.41M $5.31M $203.01M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$34.88M -$31.1M -$71.53M
Cash from investing -$0.021M $0.02M -$72.92M
Cash from financing $28.82M $0.005M $322.98M
Net change in cash -$6.08M -$31.07M $178.53M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders